Feasibility Study of Transit Dosimetry (TD) with an Electronic Portal Imaging Device (EPID) in volumetric arc therapy (VMAT) for head and neck cancer (HNC)

Document Type : Original Paper

Authors

1 Department of Radiation Oncology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India

2 Graphic Era Deemed to be University, Dehradun, Uttarakhand, India

3 Sarvodaya Hospital & Research Centre, Faridabad (Delhi/NCR), India 121006

4 Department of Radiation Oncology, All India Institute of Medical Sciences (AIIMS), Rishikesh, Uttarakhand, India

10.22038/ijmp.2025.78427.2387

Abstract

Introduction: The progress in radiotherapy treatment modalities, such as Intensity Modulated Radiotherapy (IMRT) and Volumetric Arc Therapy (VMAT), introduces considerable complexity. Consequently, the precision of dose delivery in treatment becomes crucial. This dosimetric investigation aims to integrate transit dosimetry into routine clinical procedures and assess outcomes using the gamma analysis methodology.
Material and Methods: This dosimetric investigation selected a cohort comprising 30 patients diagnosed with head and neck cancer (HNC) and treated using TruebeamTM & HalcyonTM medical linear accelerators (Varian Medical Systems, Palo Alto, CA). Nine hundred forty-two treatment fluence maps were generated using transit dosimetry and evaluated with gamma analysis. The dosimetry was performed using amorphous silicon (a-Si 1000 and a-Si 1200) electronic portal imaging devices (EPIDs), with gamma analysis criteria of 2% dose difference (DD) and 2 mm distance to agreement (DTA), as well as 3% DD and 3 mm DTA.
Results: Daily treatment consistency was assessed by establishing the initial-day fluence as the reference for the entire treatment regimen. In all instances, it was observed that the area gamma value was <1, exceeding 95% compliance when applying the 2%, 2 mm, and 3%, 3 mm criteria. This indicates a favourable agreement between the fluence of the reference day and subsequent treatment sessions throughout the course of treatment.
Conclusion: The findings of this dosimetric investigation demonstrate the successful integration of transit dosimetry into routine clinical procedures, providing assurance in dose verification without imparting additional doses to patients. Consequently, this dosimetric approach exhibits potential efficacy for dose verification purposes within clinical settings.

Keywords

Main Subjects

References

  1. Bogdanich W. Radiation offers new cures, and ways to do harm. New York Times. 2010 Jan 23;23:A1.
  2. Baek TS, Chung EJ, Son J, Yoon M. Feasibility study on the verification of actual beam delivery in a treatment room using EPID transit dosimetry. Radiation Oncology. 2014 Dec;9:1-8.
  3. Alhazmi A, Gianoli C, Neppl S, Martins J, Veloza S, Podesta M, et al. A novel approach to EPID-based 3D volumetric dosimetry for IMRT and VMAT QA. Physics in Medicine & Biology. 2018 May 22;63(11):115002.
  4. Berry SL, Polvorosa C, Cheng S, Deutsch I, Chao KC, Wuu CS. Initial clinical experience performing patient treatment verification with an electronic portal imaging device transit dosimeter. International Journal of Radiation Oncology* Biology* Physics. 2014 Jan 1;88(1):204-9.
  5. Heijmen BJ, Pasma KL, Kroonwijk M, Althof VG, De Boer JC, Visser AG, et al. Portal dose measurement in radiotherapy using an electronic portal imaging device (EPID). Physics in Medicine & Biology. 1995 Nov 1;40(11):1943.
  6. McCurdy BM, Luchka K, Pistorius S. Dosimetric investigation and portal dose image prediction using an amorphous silicon electronic portal imaging device. Medical physics. 2001 Jun;28(6):911-24.
  7. Greer PB, Popescu CC. Dosimetric properties of an amorphous silicon electronic portal imaging device for verification of dynamic intensity modulated radiation therapy. Medical physics. 2003 Jul;30(7):1618-27.
  8. McDermott LN, Louwe RJ, Sonke JJ, Van Herk MB, Mijnheer BJ. Dose–response and ghosting effects of an amorphous silicon electronic portal imaging device. Medical physics. 2004 Feb;31(2):285-95.
  9. Low DA, Harms WB, Mutic S, Purdy JA. A technique for the quantitative evaluation of dose distributions. Medical physics. 1998 May;25(5):656-61.
  10. Klein EE, Hanley J, Bayouth J, Yin FF, Simon W, Dresser S, et al. Task Group 142 report: Quality assurance of medical accelerators a. Medical physics. 2009 Sep;36(9Part1):4197-212.
  11. Yoo S, Kim GY, Hammoud R, Elder E, Pawlicki T, Guan H, et al. A quality assurance program for the on‐board. Medical physics. 2006 Nov;33(11):4431-47.
  12. Van Esch A, Depuydt T, Huyskens DP. The use of an aSi-based EPID for routine absolute dosimetric pre-treatment verification of dynamic IMRT fields. Radiotherapy and oncology. 2004 May 1;71(2):223-34.
  13. Ling CC, Zhang P, Archambault Y, Bocanek J, Tang G, LoSasso T. Commissioning and quality assurance of RapidArc radiotherapy delivery system. International Journal of Radiation Oncology* Biology* Physics. 2008 Oct 1;72(2):575-81.
  14. Agnew A, Agnew CE, Grattan MW, Hounsell AR, McGarry CK. Monitoring daily MLC positional errors using trajectory log files and EPID measurements for IMRT and VMAT deliveries. Physics in Medicine & Biology. 2014 Apr 15;59(9):N49.
  15. Pasler M, Kaas J, Perik T, Geuze J, Dreindl R, Künzler T, et al. Linking log files with dosimetric accuracy–A multi-institutional study on quality assurance of volumetric modulated arc therapy. Radiotherapy and Oncology. 2015 Dec 1;117(3):407-11.
  16. Dogan N, Mijnheer BJ, Padgett K, Nalichowski A, Wu C, Nyflot MJ, et al. AAPM Task Group Report 307: use of EPIDs for patient‐specific IMRT and VMAT QA. Medical Physics. 2023 Aug;50(8):e865-903.
  17. Nailon WH, Welsh D, McDonald K, Burns D, Forsyth J, Cooke G, et al. EPID‐based in vivo dosimetry using Dosimetry Check™: overview and clinical experience in a 5‐yr study including breast, lung, prostate, and head and neck cancer patients. Journal of Applied Clinical Medical Physics. 2019 Jan;20(1):6-16.
  18. Kimura Y, Kadoya N, Tomori S, Oku Y, Jingu K. Error detection using a convolutional neural network with dose difference maps in patient-specific quality assurance for volumetric modulated arc therapy. Physica Medica. 2020 May 1;73:57-64.
  19. Vial P, Gustafsson H, Oliver L, Baldock C, Greer PB. Direct-detection EPID dosimetry: investigation of a potential clinical configuration for IMRT verification. Physics in Medicine & Biology. 2009 Nov 11;54(23):7151.
  20. Warkentin B, Steciw S, Rathee S, Fallone BG. Dosimetric IMRT verification with a flat‐panel EPID. Medical physics. 2003 Dec;30(12):3143-55.
  21. Ezzell GA, Burmeister JW, Dogan N, LoSasso TJ, Mechalakos JG, Mihailidis D, et al. IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119. Medical physics. 2009 Nov;36(11):5359-73.
  22. Miften M, Olch A, Mihailidis D, Moran J, Pawlicki T, Molineu A, et al. Tolerance limits and methodologies for IMRT measurement‐based verification QA: recommendations of AAPM Task Group No. 218. Medical physics. 2018 Apr;45(4):e53-83.
  23. Eclipse Photon and Electron Algorithms Reference Guide. Publication ID: P1053284-001-A. June 2022.
  24. Lee C, Menk F, Cadman P, Greer PB. A simple approach to using an amorphous silicon EPID to verify IMRT planar dose maps. Medical physics. 2009 Mar;36(3):984-92.
  25. Zwan BJ, Barnes MP, Hindmarsh J, Lim SB, Lovelock DM, Fuangrod T, et al. Commissioning and quality assurance for VMAT delivery systems: an efficient time‐resolved system using real‐time EPID imaging. Medical Physics. 2017 Aug;44(8):3909-22.
  26. Mijnheer B, Jomehzadeh A, González P, Olaciregui-Ruiz I, Rozendaal R, Shokrani P, et al. Error detection during VMAT delivery using EPID-based 3D transit dosimetry. Physica Medica. 2018 Oct 1;54:137-45.
  27. Rasaei A, Rooshenas R. Evaluation of a fast method of EPID-based dosimetry for IMRT and Comparison with 3D EPID-based dosimetry system using conventional two-and three-dimensional detectors for VMAT. Iranian Journal of Medical Physics. 2018 Dec 1;15:468.
  28. Nigam J, Kumar P, Singh PP. Comparison of Patient-Specific Quality Assurance of 6 MV and 10 MV VMAT plan at Isocenter using Improved Gamma Evaluation Algorithm. Iranian Journal of Medical Physics/Majallah-I Fīzīk-I Pizishkī-i Īrān. 2022 Sep 1;19(5).
  29. Khan RF, Ostapiak OZ, Szabo JJ. An empirical model of electronic portal imager response implemented within a commercial treatment planning system for verification of intensity‐modulated radiation therapy fields. Journal of applied clinical medical physics. 2008 Sep;9(4):135-50.
Iranian Journal of Medical Physics
Volume 22, Issue 1
January and February 2025
Pages 28-35

Files

History

  • Receive Date: 29 February 2024
  • Revise Date: 04 March 2025
  • Accept Date: 09 April 2025

Share

How to cite

Statistics